The Respiratory Technology Group links fundamental respiratory science, like molecular pharmacology and cell biology, with clinical research, like physiology, epidemiology and clinical management.
The group, established in 2012, is a leader in the areas of drug formulation, device development, characterisation and delivery.
Researchers work from our state-of-the-art laboratory facilities purpose-built in 2024 at Macquarie Park.





